InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications. Research title with ★ indicates InBody recommended paper.
Sodium-glucose cotransporter 2 inhibition with dapagliflozin ameliorates extracellular volume expansion in diabetic kidney dise
Endocrinology
Nephrology
Author
T Masuda et al.
Full text